Gainers
-
Axsome Therapeutics, Inc. (NASDAQ: AXSM) surged 161.22 percent to close at $6.87 on Friday after the company
disclosed that it has achieved its primary endpoint in its Phase 2 trial for major depressive disorder..
-
Luxoft Holding, Inc. (NYSE: LXFT) shares
jumped 81.96 percent to close at $57.68 after the company announced it is being acquired by DXC for $2 billion.
-
Loxo Oncology, Inc. (NASDAQ: LOXO)
rose 66.33 percent to close at $232.65 after the company received an acquisition offer from Eli Lilly (NYSE:
LLY) at $235/Share in cash.
-
Insmed Incorporated (NASDAQ: INSM)
gained 43.23 percent to close at $21.27 after climbing 6.76 percent on Friday.
-
Sage Therapeutics, Inc. (NASDAQ: SAGE)
climbed 42.68 percent to close at $139.13 after the company disclosed that its SAGE-217 met its primary and secondary endpoints
in its Phase 3 clinical trial in postpartum depression.
-
QEP Resources, Inc. (NYSE: QEP) rose 40.3
percent to close at $8.53 after Elliott Management made an offer to acquire the company.
-
CLPS Inc (NASDAQ: CLPS) climbed 28.34
percent to close at $3.17.
-
ION Geophysical Corporation (NYSE: IO)
climbed 27.83 percent to close at $7.67.
-
Roku, Inc. (NASDAQ: ROKU) gained 25.05
percent to close at $42.18 after the company reported estimated Q4 active accounts have increased since last year and streaming
hours are up 68%. The company also announced a partnership with Westinghouse.
-
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose 23.24 percent to close at $72.75. Reata Pharmaceuticals named
Geoffrey A. Block, M.D., as Vice President, Nephrology.
-
Taiwan Liposome Company, Ltd. (NASDAQ: TLC) rose 22.52 percent to close at $7.29.
-
ASV Holdings Inc (NASDAQ: ASV) gained
21.12 percent to close at $3.2400.
-
Lannett Company, Inc. (NYSE: LCI) rose
20.59 percent to close at $7.32.
-
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) jumped 20.15 percent to close at $3.2200.
-
Clovis Oncology, Inc. (NASDAQ: CLVS)
jumped 18.48 percent to close at $21.73 after reporting product revenue for Q4 and 2018.
-
CARBO Ceramics Inc. (NYSE: CRR) gained
18.43 percent to close at $4.82 after the company issued strong sales outlook.
-
Basic Energy Services, Inc. (NYSE: BAS)
rose 18.37 percent to close at $5.80.
-
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 18.22 percent to close at $10.25 after the company secured
$75 million of credit financing with HealthCare Royalty Partners.
-
Bristow Group Inc. (NYSE: BRS) shares
jumped 17.89 percent to close at $3.36.
-
Leap Therapeutics, Inc. (NASDAQ: LPTX)
surged 17.58 percent to close at $3.0100.
-
Invitae Corporation (NYSE: NVTA) surged
16.44 percent to close at $13.60 after reporting 2018 preliminary financial results.
-
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) gained 16.33 percent to close at $11.54
-
PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) climbed 15.17 percent to close at $3.72.
-
Exact Sciences Corporation (NASDAQ: EXAS) rose 14.79 percent to close at $75.36 after the company issued strong
revenue forecast.
-
Phunware Inc (NASDAQ: PHUN) rose 14.69
percent to close at $62.00.
-
LGI Homes, Inc. (NASDAQ: LGIH) gained
14.45 percent to close at $55.99.
-
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) climbed 14.31 percent to close at $6.07.
-
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) rose 14.17 percent to close at $5.64.
-
Blueprint Medicines Corporation (NASDAQ: BPMC) gained 14.14 percent to close at $61.04.
-
Inpixon (NASDAQ: INPX) climbed 14.11
percent to close at $3.72.
-
Titan International, Inc. (NYSE: TWI)
rose 14.07 percent to close at $5.92.
-
Evolus, Inc. (NASDAQ: EOLS) climbed
13.69 percent to close at $15.45.
-
Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 13.5 percent to close at $3.11.
-
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) gained 13.41 percent to close at $24.35.
-
Galectin Therapeutics, Inc. (NASDAQ: GALT) surged 13.33 percent to close at $4.59.
-
Apyx Medical Corporation (NASDAQ: APYX) gained 13.14 percent to close at $7.49. Apyx Medical expects Q4 sales of
$5.90 million to 6.10 million.
-
CRISPR Therapeutics AG (NASDAQ: CRSP)
climbed 13.05 percent to close at $34.22.
-
i3 Verticals, Inc. (NASDAQ: IIIV)
gained 12.91 percent to close at $26.59.
-
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 12.46 percent to close at $3.2500 after the company disclosed that
it has received its Canada Cannabis license.
-
SilverSun Technologies, Inc. (NASDAQ: SSNT) rose 11.4 percent to close at $2.2280.
-
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) gained 9.57 percent to close at $81.86 after the company announced it
expects Q4 net product sales to have doubled since last year.
-
Merus N.V. (NASDAQ: MRUS) jumped 9.57
percent to close at $15.45 after reporting IND clearance for MCLA-145.
-
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) rose 8.47 percent to close at $3.20.
-
Diebold Nixdorf, Incorporated (NYSE: DBD)
rose 7.98 percent to close at $2.8400 after dropping 2.59 percent on Friday.
-
Selecta Biosciences, Inc. (NASDAQ: SELB) rose 7.44 percent to close at $2.6000.
-
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) gained 6.91 percent to close at $43.77 after the company reported
positive long-term data from the open-label extension of the Phase 2 OASIS trial.
-
General Electric Company (NYSE: GE) shares
rose 6.2 percent to close at $8.74 following reports that Apollo is considering GE's jet-leasing business.
Losers
-
Maxar Technologies Ltd. (NYSE: MAXR)
dipped 31.48 percent to close at $8.03 after the company reported failure of its WorldView-4 Satellite.
-
Natural Health Trends Corp. (NASDAQ: NHTC) dropped 24.73 percent to close at $14.88 on Friday. Natural Health
Trends rejected false allegations in CCTV report and reiterated commitment to ethical business practices.
-
AxoGen, Inc. (NASDAQ: AXGN) dropped
23.18 percent to close at $16.37. AxoGen expects Q4 sales of at least $23.4 million and FY18 sales of at least $83.9 million.
-
PG&E Corporation (NYSE: PCG) dropped
22.34 percent to close at $18.95 after CNBC reported the company could face a minimum of $30 billion in liabilities related to
California wildfires in 2017 and 2018, citing unnamed sources.The report comes after a Reuters story over the weekend suggested
the utility is considering a bankruptcy filing and will potentially be taking a major financial charge in Q4.
-
Cutera, Inc. (NASDAQ: CUTR) dropped
21.66 percent to close at $13.27 after reporting resignation of CEO and President James Reinstein.
-
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) shares dipped 19.55 percent to close at $15.06 after the company issued
full-year 2019 guidance.
-
Hi-Crush Partners LP (NYSE: HCLP)
tumbled 15.67 percent to close at $3.66 after the company reported Q4 sales volumes fell 29% Q/Q and suspended its quarterly
distribution.
-
electroCore, Inc. (NASDAQ: ECOR)
dropped 12.92 percent to close at $7.28.
-
Translate Bio, Inc. (NASDAQ: TBIO)
declined 12.65 percent to close at $7.32.
-
Select Medical Holdings Corporation (NYSE: SEM) fell 12.49 percent to close at $14.08.
-
FTE Networks, Inc. (NYSE: FTNW) dropped
12.4 percent to close at $3.32.
-
scPharmaceuticals Inc. (NASDAQ: SCPH)
shares declined 12.01 percent to close at $3.37.
-
MOGU Inc. (NYSE: MOGU) fell 11.9 percent
to close at $18.66 after dropping 6.70 percent on Friday.
-
Yangtze River Port and Logistics Limited (NASDAQ: YRIV) dropped 11.51 percent to close at $3.23.
-
LRAD Corporation (NASDAQ: LRAD) fell
11.37 percent to close at $2.26.
-
Myriad Genetics, Inc. (NASDAQ: MYGN)
fell 10.66 percent to close at $27.98.
-
Diplomat Pharmacy, Inc. (NYSE: DPLO)
fell 10.5 percent to close at $12.62. Diplomat Pharmacy narrowed its FY2018 sales guidance.
-
NuVasive, Inc. (NASDAQ: NUVA) shares
declined 9.19 percent to close at $45.45.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.